Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancerUENO, Hideki; OKUSAKA, Takuji; IKEDA, Masafumi et al.Oncology. 2004, Vol 67, Num 3-4, pp 215-221, issn 0030-2414, 7 p.Article

Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapyUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Oncology. 2000, Vol 59, Num 4, pp 296-301, issn 0030-2414Article

Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapyIKEDA, Masafumi; OKADA, Shuichi; TOKUUYE, Koichi et al.Cancer. 2001, Vol 91, Num 3, pp 490-495, issn 0008-543XArticle

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinomaIKEDA, Masafumi; OKUSAKA, Takuji; UENO, Hideki et al.Cancer. 2005, Vol 103, Num 4, pp 756-762, issn 0008-543X, 7 p.Article

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinomaUENO, Hideki; OKADA, Shuichi; OKUSAKA, Takuji et al.Cancer chemotherapy and pharmacology. 2002, Vol 49, Num 2, pp 155-160, issn 0344-5704Article

Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injectionKUUIYAMA, Hitoshi; OKADA, Shuichi; OKUSAKA, Takuji et al.Journal of gastroenterology and hepatology. 2002, Vol 17, Num 11, pp 1205-1210, issn 0815-9319, 6 p.Article

Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients: Impact of Genetic PolymorphismsSUGIYAMA, Emiko; KANIWA, Nahoko; YAMAMOTO, Noboru et al.Clinical pharmacokinetics. 2010, Vol 49, Num 8, pp 549-558, issn 0312-5963, 10 p.Article

Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment?HASHIMOTO, Kenji; UENO, Hideki; IKEDA, Masafumi et al.Oncology. 2009, Vol 77, Num 3-4, pp 217-223, issn 0030-2414, 7 p.Article

Severe drug toxicity associated with a single-nucleotide polymorphism of the Cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatinYONEMORI, Kan; UENO, Hideki; KIM, Su-Ryang et al.Clinical cancer research. 2005, Vol 11, Num 7, pp 2620-2624, issn 1078-0432, 5 p.Article

A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerUENO, Hideki; OKUSAKA, Takuji; IKEDA, Masafumi et al.Oncology. 2005, Vol 69, Num 5, pp 421-427, issn 0030-2414, 7 p.Article

Predictive factors for tumor response to chemotherapy in patients with pancreatic cancerFUJISHIRO, Mitsuhiro; OKADA, Shuichi; UENO, Hideki et al.Hepato-gastroenterology. 2000, Vol 47, Num 36, pp 1744-1746, issn 0172-6390Article

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokineticsSUNAKAWA, Yu; FURUSE, Junji; OKUSAKA, Takuji et al.Investigational new drugs. 2014, Vol 32, Num 1, pp 104-112, issn 0167-6997, 9 p.Article

Successful Everolimus Treatment in a Patient with Advanced Pancreatic Neuroendocrine Tumor Who Developed Everolimus-Induced Interstitial Lung Disease on Two Occasions: A Case ReportNAKAYAMA, Yusuke; IKEDA, Masafumi; OKUSAKA, Takuji et al.Chemotherapy (Basel). 2013, Vol 59, Num 1, pp 74-78, issn 0009-3157, 5 p.Article

Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancerIMOTO, Akira; MITSUNAGA, Shuichi; INAGAKI, Masatoshi et al.International journal of cancer (Print). 2012, Vol 131, Num 12, pp 2795-2807, issn 0020-7136, 13 p.Article

Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findingsOKUSAKA, Takuji; OKADA, Shuichi; UENO, Hideki et al.Pancreas. 2001, Vol 22, Num 3, pp 279-284, issn 0885-3177Article

DOSE―VOLUME HISTOGRAM ANALYSIS OF THE SAFETY OF PROTON BEAM THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMAKAWASHIMA, Mitsuhiko; KOHNO, Ryosuke; ZENDA, Sadamoto et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 5, pp 1479-1486, issn 0360-3016, 8 p.Article

Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis CIKEDA, Masafumi; FUJIYAMA, Shigetoshi; TANAKA, Motohiko et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 1, pp 122-128, issn 0815-9319, 7 p., 1Article

Primary hepatocellular carcinoma detected long after tumor markers and lymph node metastases : Beyond our vision?HUANG, Jee-Fu; TAKAYASU, Kenichi; OKADA, Shuichi et al.Digestive diseases and sciences. 2006, Vol 51, Num 3, pp 610-615, issn 0163-2116, 6 p.Article

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinomaIKEDA, Masafumi; SHIINA, Shuichiro; ASAOKA, Yoshinari et al.Investigational new drugs. 2014, Vol 32, Num 5, pp 928-936, issn 0167-6997, 9 p.Article

A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisIKEDA, Masafumi; OKUSAKA, Takuji; FURUSE, Junji et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 2, pp 463-470, issn 0344-5704, 8 p.Article

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patientsMORIZANE, Chigusa; OKUSAKA, Takuji; SUZUKI, Eiichiro et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 4, pp 957-964, issn 0344-5704, 8 p.Article

A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinomaKANAI, Fumihiko; YOSHIDA, Haruhiko; MORIZANE, Chigusa et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 315-324, issn 0344-5704, 10 p.Article

A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancerNAKACHI, Kohei; FURUSE, Junji; KINOSHITA, Taira et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 3, pp 527-534, issn 0344-5704, 8 p.Article

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 CasesSUZUKI, Eiichiro; FURUSE, Junji; KOJIMA, Yasushi et al.Oncology. 2010, Vol 79, Num 1-2, pp 39-45, issn 0030-2414, 7 p.Article

A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolizationTANAKA, Tsutomu; IKEDA, Masafumi; OKUSAKA, Takuji et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 4, pp 683-688, issn 0344-5704, 6 p.Article